Aisling Capital Management LP Long-Term Concentrated

Location: New York, NY

CIK: 0001766721 · Show all filings

Period: Q4 2019 (← Previous) (Next →)

Filing Date: Feb 6, 2020

Total Value: $261M (100.0% shares, 0.0% debt)

Holdings (13)

BBIO BridgeBio (BBIO) 51.5%

Value $134M Shares 3,835,722 Est. Cost $27.26 Unrealized +1.7%

— Eidos Therapeutics, Inc. (EIDIX) 24.7%

Value $64.48M Shares 1,123,630 Est. Cost $13.76 Unrealized —

— AVROBIO, Inc. (AVRO) 6.9%

Value $17.98M Shares 893,079 Est. Cost $16.87 Unrealized —

— Aeglea Biotherapeutics Inc (AGLE) 3.8%

Value $9.864M Shares 1,291,151 Est. Cost $7.61 Unrealized —

— Atreca (BCEL) 2.3%

Value $5.997M Shares 387,653 Est. Cost $18.84 Unrealized —

— Marker Therapeutics, Inc. (MRKR) 2.2%

Value $5.76M Shares 2,000,000 Est. Cost $5.55 Unrealized —

— ObsEva SA (OBSV) 2.0%

Value $5.296M Shares 1,386,338 Est. Cost $12.66 Unrealized —

— Zosano Pharma Corporation (ZSAN) 1.6%

Value $4.132M Shares 2,718,226 Est. Cost $2.15 Unrealized —

— Sunesis Pharmaceuticals, Inc. (SNSS) 1.3%

Value $3.411M Shares 10,100,000 Est. Cost $0.89 Unrealized —

RCUS Arcus Biosciences, Inc. (RCUS) 1.3%

Value $3.367M Shares 333,333 Est. Cost $11.67 Unrealized -28.0%

— Verona Pharma plc (VRNA) 1.0%

Value $2.551M Shares 443,596 Est. Cost $9.65 Unrealized —

— Nabriva Therapeutics plc (NBRV) 1.0%

Value $2.522M Shares 1,910,287 Est. Cost $1.49 Unrealized —

ACRS Aclaris Theraputics Inc (ACRS) 0.5%

Value $1.199M Shares 634,455 Est. Cost $10.31 Unrealized -83.9%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BridgeBio (BBIO)	3,835,722	$134M	51.5%	$27.26	+1.7%	COM	10806X102
—	Eidos Therapeutics, Inc. (EIDIX)	1,123,630	$64.48M	24.7%	$13.76	—	COM	28249H104
—	AVROBIO, Inc. (AVRO)	893,079	$17.98M	6.9%	$16.87	—	COM	05455M100
—	Aeglea Biotherapeutics Inc (AGLE)	1,291,151	$9.864M	3.8%	$7.61	—	COM	00773J103
—	Atreca (BCEL)	387,653	$5.997M	2.3%	$18.84	—	CL A COM	04965G109
—	Marker Therapeutics, Inc. (MRKR)	2,000,000	$5.76M	2.2%	$5.55	—	COM	57055L107
—	ObsEva SA (OBSV)	1,386,338	$5.296M	2.0%	$12.66	—	COM	H5861P103
—	Zosano Pharma Corporation (ZSAN)	2,718,226	$4.132M	1.6%	$2.15	—	COM	98979H202
—	Sunesis Pharmaceuticals, Inc. (SNSS)	10,100,000	$3.411M	1.3%	$0.89	—	COM	867328700
RCUS	Arcus Biosciences, Inc. (RCUS)	333,333	$3.367M	1.3%	$11.67	-28.0%	COM	03969F109
—	Verona Pharma plc (VRNA)	443,596	$2.551M	1.0%	$9.65	—	COM	925050106
—	Nabriva Therapeutics plc (NBRV)	1,910,287	$2.522M	1.0%	$1.49	—	SHS	G63637105
ACRS	Aclaris Theraputics Inc (ACRS)	634,455	$1.199M	0.5%	$10.31	-83.9%	COM	00461U105